EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 152 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.87 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $309,000 | -10.4% | 5,790 | 0.0% | 0.11% | -15.3% |
| Q3 2017 | $345,000 | -6.2% | 5,790 | +24.1% | 0.13% | -10.9% |
| Q2 2017 | $368,000 | +4.0% | 4,665 | +9.4% | 0.15% | -2.0% |
| Q1 2017 | $354,000 | +4.1% | 4,265 | -0.6% | 0.15% | -6.8% |
| Q4 2016 | $340,000 | -3.1% | 4,290 | -14.5% | 0.16% | 0.0% |
| Q3 2016 | $351,000 | -82.3% | 5,015 | -77.6% | 0.16% | -82.2% |
| Q4 2015 | $1,984,000 | +19.8% | 22,375 | 0.0% | 0.91% | +14.7% |
| Q3 2015 | $1,656,000 | +46.9% | 22,375 | +60.5% | 0.79% | +75.2% |
| Q2 2015 | $1,127,000 | – | 13,940 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
| TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
| Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
| Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
| Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |